David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Westlake Corp
WLK
$9.6B
| $543K | ﹤0.01% |
3,878
-28,377
| -88% | -$3.6M |
|
3327
PUT
Range Resources
RRC
$9.6B
| $542K | ﹤0.01% |
+17,800
| New | +$584K |
|
3328
Allegro MicroSystems
ALGM
$6.89B
| $542K | ﹤0.01% |
17,890
-99,122
| -85% | -$2.83M |
|
3329
AvePoint
AVPT
$2.77B
| $541K | ﹤0.01% |
65,883
+18,433
| +39% | +$144K |
|
3330
First Trust Energy AlphaDEX Fund
FXN
$393M
| $541K | ﹤0.01% |
+32,399
| New | +$552K |
|
|
ABLLW
3331
DELISTED
Abacus Life Warrant
ABLLW
| $540K | ﹤0.01% |
729,890
+229,890
| +46% | +$91.1K |
|
3332
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$744M
| $539K | ﹤0.01% |
+9,536
| New | +$533K |
|
3333
CorMedix
CRMD
$654M
| $539K | ﹤0.01% |
143,277
-42,972
| -23% | -$148K |
|
3334
Future Fuel
FF
$239M
| $539K | ﹤0.01% |
+88,602
| New | +$565K |
|
3335
Best Buy
BBY
$18.1B
| $536K | ﹤0.01% |
6,848
-755,113
| -99% | -$53.2M |
|
3336
CALL
CGI
GIB
$15.4B
| $535K | ﹤0.01% |
5,000
| – | – |
|
3337
Karyopharm Therapeutics
KPTI
$44.2M
| $534K | ﹤0.01% |
41,148
-376
| -0.9% | -$5.07K |
|
3338
Gran Tierra Energy
GTE
$343M
| $534K | ﹤0.01% |
+94,624
| New | +$588K |
|
3339
Aura Biosciences
AURA
$820M
| $532K | ﹤0.01% |
+60,064
| New | +$509K |
|
3340
PUT
Everest Group
EG
$14.4B
| $530K | ﹤0.01% |
1,500
| – | – |
|
3341
Atara Biotherapeutics
ATRA
$99.1M
| $530K | ﹤0.01% |
41,360
-115,057
| -74% | -$2.68M |
|
3342
Acumen Pharmaceuticals
ABOS
$221M
| $530K | ﹤0.01% |
+138,029
| New | +$410K |
|
3343
Immersion
IMMR
$252M
| $529K | ﹤0.01% |
74,912
-143,206
| -66% | -$952K |
|
3344
TriplePoint Venture Growth BDC
TPVG
$219M
| $526K | ﹤0.01% |
+48,456
| New | +$496K |
|
3345
Jack Henry & Associates
JKHY
$12.2B
| $526K | ﹤0.01% |
3,220
-5,500
| -63% | -$842K |
|
3346
Benchmark Electronics
BHE
$2.57B
| $526K | ﹤0.01% |
19,017
-42,967
| -69% | -$1.08M |
|
|
LAND
3347
Gladstone Land Corp
LAND
$375M
| $525K | ﹤0.01% |
36,329
+25,644
| +240% | +$365K |
|
|
TBMC
3348
DELISTED
Trailblazer Merger Corp I
TBMC
| $523K | ﹤0.01% |
50,000
| – | – |
|
|
GODN
3349
DELISTED
Golden Star Acquisition Corporation Ordinary Shares
GODN
| $521K | ﹤0.01% |
50,000
| – | – |
|
3350
Travel + Leisure Co
TNL
$4.49B
| $520K | ﹤0.01% |
13,301
-95,981
| -88% | -$3.48M |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.